OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox-dependent structure and dynamics of macrophage migration inhibitory factor reveal sites of latent allostery
Erin Skeens, Meagan Gadzuk-Shea, Dilip Shah, et al.
Structure (2022) Vol. 30, Iss. 6, pp. 840-850.e6
Open Access | Times Cited: 14

Showing 14 citing articles:

Hallmarks of Cancer Affected by the MIF Cytokine Family
Romina Mora Barthelmess, Benoı̂t Stijlemans, Jo A. Van Ginderachter
Cancers (2023) Vol. 15, Iss. 2, pp. 395-395
Open Access | Times Cited: 29

OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
Michael Thiele, Seamas C. Donnelly, Robert A. Mitchell
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005475-e005475
Open Access | Times Cited: 38

2,5-Pyridinedicarboxylic acid is a bioactive and highly selective inhibitor of D-dopachrome tautomerase
Andrew Parkins, Pragnya Das, Varsha Prahaladan, et al.
Structure (2023) Vol. 31, Iss. 3, pp. 355-367.e4
Open Access | Times Cited: 10

Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic
Gregor Rossmueller, Irina Mirkina, Barbara Maurer, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 5, pp. 555-569
Open Access | Times Cited: 10

D‐dopachrome tautomerase in cardiovascular and inflammatory diseases—A new kid on the block or just another MIF?
Chunfang Zan, Bishan Yang, Markus Brandhofer, et al.
The FASEB Journal (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 15

Preferential Secretion of Oxidation-Sensitive Proteins by Unconventional Pathways: Why is This Important for Inflammation?
Marco E. Bianchi, Anna Rubartelli, Roberto Sitia
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 10-12, pp. 693-705
Closed Access | Times Cited: 1

Redox-dependent plasticity of oxMIF facilitates its interaction with CD74 and therapeutic antibodies
Sara Sajko, Erin Skeens, Alexander Schinagl, et al.
Redox Biology (2024) Vol. 75, pp. 103264-103264
Open Access | Times Cited: 1

Stereochemical Control of Redox CoII/CoIII-Cages with Switchable Cotton Effects Based on Labile-Static States
Yu‐Lin Lu, Kai Wu, Yin‐Hui Huang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 29, pp. 20414-20424
Closed Access | Times Cited: 1

Cytokine aerobics: Oxidation controls cytokine dynamics and function
Markus Brandhofer, Jürgen Bernhagen
Structure (2022) Vol. 30, Iss. 6, pp. 787-790
Open Access | Times Cited: 3

Integrating In Silico and In Vitro Tools for Optimized Antibody Development—Design of Therapeutic Anti-oxMIF Antibodies
Gregor Rossmueller, Irina Mirkina, Michael Thiele, et al.
Antibodies (2024) Vol. 13, Iss. 4, pp. 104-104
Open Access

Oxidized MIF is an Alzheimer’s Disease drug target relaying external risk factors to tau pathology
Andreas Müller‐Schiffmann, Felix Torres, Anatolly Kitaygorodskyy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Page 1

Scroll to top